ReviewCurrent treatment options in oncology2023

Research Progress on the Cardiotoxicity of EGFR-TKIs in Non-Small Cell Lung Cancer.

Yinan Yu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.